Clostridium difficile: a formidable foe.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005
   Pooled it
2. A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.British journal of clinical pharmacology · 2008
   Trial
3. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.PloS one · 2017
   Article
4. Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections.American journal of infection control · 2012
   Article
5. Development and validation of a Clostridium difficile infection risk prediction model.Infection control and hospital epidemiology · 2011
   Article
6. Antiapoptotic proteins Bcl-2 and Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells.Infection and immunity · 2009
   Article
7. Clostridium difficile: how much do hospital staff know about it?Annals of the Royal College of Surgeons of England · 2009
   Article
8. Prevention and control of infections in the home.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2009
   Review
9. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.World journal of gastroenterology · 2008
   Article
10. Hypervirulent strains of Clostridium difficile.Postgraduate medical journal · 2007
    Review
11. Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.Journal of bacteriology · 2006
    Article
12. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.Antimicrobial agents and chemotherapy · 2006
    Article
13. Key research issues in Clostridium difficile.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2005
    Article
14. First, the bad news...CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2004
    Article

Corrections and comments

• Comment on
  Clostridium difficile-associated diarrhea in adults.2004

Authors and funding

13 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as